NO953311L - Anvendelse av anti-helmint-vaksiner ved kontroll av parasittsykdom i forbindelse med tap av naturlig immunitet - Google Patents

Anvendelse av anti-helmint-vaksiner ved kontroll av parasittsykdom i forbindelse med tap av naturlig immunitet

Info

Publication number
NO953311L
NO953311L NO953311A NO953311A NO953311L NO 953311 L NO953311 L NO 953311L NO 953311 A NO953311 A NO 953311A NO 953311 A NO953311 A NO 953311A NO 953311 L NO953311 L NO 953311L
Authority
NO
Norway
Prior art keywords
helminth
loss
natural immunity
control
connection
Prior art date
Application number
NO953311A
Other languages
English (en)
Norwegian (no)
Other versions
NO953311D0 (no
Inventor
Timothy Peter Rolph
Stuart John Andrews
Original Assignee
Mallinckrodt Veterinary Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mallinckrodt Veterinary Inc filed Critical Mallinckrodt Veterinary Inc
Publication of NO953311D0 publication Critical patent/NO953311D0/no
Publication of NO953311L publication Critical patent/NO953311L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0003—Invertebrate antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Immunology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NO953311A 1993-02-24 1995-08-23 Anvendelse av anti-helmint-vaksiner ved kontroll av parasittsykdom i forbindelse med tap av naturlig immunitet NO953311L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB939303681A GB9303681D0 (en) 1993-02-24 1993-02-24 Vaccines
PCT/GB1994/000354 WO1994019010A1 (en) 1993-02-24 1994-02-23 The use of anti-helminth vaccines in the control of parasite disease associated with loss of natural immunity

Publications (2)

Publication Number Publication Date
NO953311D0 NO953311D0 (no) 1995-08-23
NO953311L true NO953311L (no) 1995-10-19

Family

ID=10730938

Family Applications (1)

Application Number Title Priority Date Filing Date
NO953311A NO953311L (no) 1993-02-24 1995-08-23 Anvendelse av anti-helmint-vaksiner ved kontroll av parasittsykdom i forbindelse med tap av naturlig immunitet

Country Status (17)

Country Link
EP (1) EP0686041B1 (bg)
JP (1) JPH08506828A (bg)
AT (1) ATE152916T1 (bg)
AU (1) AU679494B2 (bg)
BG (1) BG61934B1 (bg)
CA (1) CA2155119A1 (bg)
CZ (1) CZ213895A3 (bg)
DE (1) DE69403197T2 (bg)
ES (1) ES2102836T3 (bg)
GB (1) GB9303681D0 (bg)
HU (1) HUT72919A (bg)
MX (1) MX9401384A (bg)
NO (1) NO953311L (bg)
NZ (1) NZ261598A (bg)
RU (1) RU2145876C1 (bg)
WO (1) WO1994019010A1 (bg)
ZA (1) ZA941237B (bg)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0815674D0 (en) * 2008-08-28 2008-10-08 Moredun Res Inst Nematode vaccine
MX2022005359A (es) 2019-11-04 2022-06-02 Revolution Medicines Inc Inhibidores de ras.
WO2023114954A1 (en) 2021-12-17 2023-06-22 Genzyme Corporation Pyrazolopyrazine compounds as shp2 inhibitors

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8906156D0 (en) * 1989-03-17 1989-05-04 Munn Edward A Production and use of anthelmintic agents and protective immunogens
GB9209993D0 (en) * 1992-05-08 1992-06-24 Munn Edward A Vaccines
ZW8893A1 (en) * 1992-07-21 1994-06-01 Pitman Moore Inc Vaccines

Also Published As

Publication number Publication date
ES2102836T3 (es) 1997-08-01
NO953311D0 (no) 1995-08-23
WO1994019010A1 (en) 1994-09-01
ATE152916T1 (de) 1997-05-15
NZ261598A (en) 1997-03-24
AU679494B2 (en) 1997-07-03
BG99888A (bg) 1996-04-30
RU2145876C1 (ru) 2000-02-27
JPH08506828A (ja) 1996-07-23
AU6041594A (en) 1994-09-14
DE69403197T2 (de) 1997-08-28
EP0686041A1 (en) 1995-12-13
ZA941237B (en) 1994-09-19
MX9401384A (es) 1994-08-31
DE69403197D1 (de) 1997-06-19
CA2155119A1 (en) 1994-09-01
BG61934B1 (bg) 1998-10-30
HU9502467D0 (en) 1995-10-30
HUT72919A (en) 1996-06-28
EP0686041B1 (en) 1997-05-14
GB9303681D0 (en) 1993-04-14
CZ213895A3 (en) 1996-03-13

Similar Documents

Publication Publication Date Title
BR0107972A (pt) Uso de uma proteìna ou polinucleotìdeo tat do hiv, nef do hiv, ou tat do hiv ligado(a) a uma proteìna ou polinucleotìdeo nef do hiv (nef-tat), e de uma proteìna ou polinucleotìdeo gp120 do hiv, método para imunizar um ser humano contra o hiv, e, composição de vacina para o uso humano
PT851927E (pt) Compostos para imunoterapia e diagnostico de tuberculose
DK1326636T3 (da) Vaccinesammensætning
ATE127345T1 (de) Stressproteine und verwendungen dafür.
TNSN07387A1 (en) C.perfringens alpha toxoid vaccine
AR008799A1 (es) Composicion de vacuna para prevenir o tratar el paludismo; uso de dicha composicion para elaborar medicamentos y metodo para dicha profilaxis y dichotratamiento
ATE270707T1 (de) Entepneumovirus und entsprechendes impfstoff
ES2070266T3 (es) Vacuna contra la infeccion por escherichia coli.
BR9712556A (pt) Plasmìdeo, composição farmacêutica, e, processo de imunizar um indivìduo contra um antìgeno
PT1024824E (pt) Composicao de vacina dispersivel solida para administracao oral
BR9704879A (pt) Composição de vacina e uso de um vírus cav vivo
ATE352315T1 (de) Neospora impstoff
NO953311D0 (no) Anvendelse av anti-helmint-vaksiner ved kontroll av parasittsykdom i forbindelse med tap av naturlig immunitet
ES2079851T3 (es) Uso de il-4 para mejorar la respuesta inmunitaria frente a inmunogenos en vacunas.
AR010568A1 (es) Polipeptido, composicion de vacuna, uso del polipeptido en la fabricacion de una composicion, y metodo para producir en un mamifero una respuestainmuno-protectora contra la infeccion de helicobacter pylori
DE69331459D1 (de) Parenterale immunisierung gegen rotavirus
ES2155510T3 (es) Vacuna mejorada para la inmunizacion contra infecciones por el virus tbe y procedimiento para su preparacion.
PT636030E (pt) Vacina de bacterina-toxoide de pasteurella haemolytica tipo a-1
ATE353226T1 (de) Adjuvanszusammensetzung enthaltend fha oder ein fha-fragment in freier form
BR9711138A (pt) Prepara-{es de herperv¡rus equino com prote-Æo mÚtua e m-todo de fazer e usar as mesmas
ATE145335T1 (de) Kreuzreaktive immunisierung gegen influenza
KR970019821A (ko) 송진을 함유한 치약 제조 방법
UA49145A (uk) Спосіб стандартизації моделювання проникної інфікованої травми заднього сегмента ока
AR010517A1 (es) Compuestos y metodos para la inmunoterapia y diagnostico de tuberculosis